This study evaluated retrospectively the effect of @entity12119 on the management of @entity2522 ( @entity2522 ). The study population consisted of 15 @entity1 with @entity2522 . @entity1 were requested to make topical application of 2% @entity12119 ointment 4 times a day for 6 weeks. Clinical assessments were recorded at baseline, at 6 weeks and 12 months after beginning the therapy. @entity1 ' examination involved lesion size area, @entity158 score and impact on daily activities. All @entity1 presented lesions in maxilla; in 9 @entity1 (60.0%) lesions were predominately at the anterior region and 6 (40.0%) at the posterior region of maxilla. Treatment significantly (p<0.05) reduced the @entity158 intensity (from 5.4  1.12 to 1.16  0.97) and its periodicity (from 53.33% with @entity158 >3 x/week to 13.33%), and the lesion size in 72.47% (  4.12) immediately after 6 weeks of treatment. Improvements were sustained for 12 months compared to baseline (p<0.001). It also reduced the impact of disease in daily activities (eating and oral hygiene performance), and improved the emotional condition of @entity1 , who reported better social relationships and habits. Topical application of @entity12119 may be a possible alternative local palliative therapy for @entity2522 treatment.

Use of @entity12119 for XXXX Treatment: 1-Year Follow-Up.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity2522 :: ('MESH:D005891', 'Disease') :: ['DG', 'desquamative gingivitis'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity12119 :: ('MESH:D005672', 'Chemical') :: ['fusidic acid']
@entity2522 :: (MESH:D005891,Disease) :: ['Desquamative Gingivitis']
